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We thank Dr. Serio and colleagues for their interest in our paper
(1) and for their letter highlighting the clinical challenge of
asymptomatic early repolarization (ER). We noted the examples of
J-point elevation in a healthy individual, 2 patients with genetic
forms of cardiomyopathy, and a mutation-negative relative. These
cases are entirely consistent with our hypothesis that ER may be an
independent clinical trait that increases arrhythmic risk in genet-
ically predisposed individuals, but they also illustrate the impor-
tance of context when deciding on the clinical significance of ER.
The fundamental clinical distinction is that between physiological
J-point elevation, which conveys little or no arrhythmic risk to an
individual, and a pathological ER phenomenon that predisposes
patients to ventricular fibrillation (VF). In population studies, the
presence of a J wave increases the risk of idiopathic VF from 3.4 per
100,000 to 11 per 100,000, making the odds that an individual has a fatal
Figure 1 Different Patterns of J-Point Elevation in Normal indivi
DCM  dilated cardiomyopathy; HCM  hypertrophic cardiomyopathy.disease 1:10,000, which is too small to influence management (2). sA variety of associated electrocardiogram (ECG) parameters
uch as the location and amplitude of J-point elevation and a shorter
T interval have been suggested as indicators of an increased risk of
F. However, data from large population cohorts have indicated that
he risk is greater in older patients with left ventricular hypertrophy
nd ischemic heart disease (3,4). These findings need confirmation in
arger independent cohorts, and they indicate that other ECG
nomalies may be important in determining the sudden death risk of
he individual. In addition, further refinement and elucidation of the
attern of ER is still merited.
Based upon our observations and current understanding of the
ole of ER in VF mechanisms, we suggest that a family history of
udden arrhythmic death syndrome (SADS), epilepsy, or unex-
lained syncope are new considerations in the interpretation of ER
n an ECG because these may indicate either pathological ER or
R in the context of a separate proarrhythmic condition.
In conclusion, at present, ER in the absence of symptoms,
tructural heart disease, or family history of SADS should not be
and in Patients With HCM and DCMdualseen as a major independent risk factor for sudden death. In patients
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evaluation of the pattern and distribution of ER in combination with
the ST-segment morphology coupled with investigation for structural
or ion channel disease (5). At present, there are no data to support the
use of prophylactic antiarrhythmic therapy in cases of isolated ER.
However, we would recommend close monitoring and a low thresh-
old for implanting a loop recorder in the context of palpitations,
pre-syncope, or syncope. The fundamental questions remain as to
what is the prognostic significance, genetic basis, and optimal therapy
of ER in the healthy population and high-risk subgroups.
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